<DOC>
	<DOCNO>NCT02648074</DOCNO>
	<brief_summary>Asthma chronic , inflammatory disease lung characterize intermittent airway obstruction , airway hyperresponsiveness , presence activate inflammatory cell , inflammatory mediator , airway structural change . Airway smooth muscle ( ASM ) cell actively participate remodelling inflammatory process proliferation , release proinflammatory cytokine , chemokines , extracellular matrix ( ECM ) proteins . Eosinophils essential inflammatory cell may importance ASM remodelling . It known eosinophil induces ASM cell proliferation via secretion cysteinyl leukotrienes asthmatic . However possible direct eosinophil-ASM cell functional interaction adhesion process . It show integrins modulate ASM proliferation contractile protein expression demonstrate allergen-induced ASM remodelling animal model allergic asthma . Wingless/integrase-1 ( WNT ) signal regulates wide range developmental process , aberrant activation lead disease . Recently , confirm gene polymorphism WNT signal pathway associate impaired lung function childhood asthma . It also find first time relevant role noncanonical WNT signal TGFβ-induced ECM expression ASM cell identify WNT-5A abundant WNT ligand increase expression asthmatic . It demonstrate WNT-5A could contribute remodelling airway . Unfortunately , effect eosinophil WNT secretion ASM cell present unknown . Despite widely acknowledge significance eosinophil asthma pathogenesis , mechanism eosinophil induce ASM remodelling unsolved .</brief_summary>
	<brief_title>Eosinophil Induced Remodelling Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Airway Remodeling</mesh_term>
	<criteria>1 . Men woman age 1850 year ; 2 . Allergic asthma sensitization house dust mite ( D. pteronyssinus ) allergen , approve : 2.1 . Medical history symptom one year 2.2. skin prick test positive D. pteronyssinus ( positive wheal exceed 3mm diameter great negative control ) 2.3 . Positive bronchial challenge methacholine document completely reversible bronchial obstruction ; 3 . Stable lung function ( FEV1≥70 perc . ) ; 4 . Postmenopausal woman . Premenopausal woman pregnancy test negative agree use effective contraceptive measure study ; 5 . Healthy subject without allergic chronic respiratory disease ( control group ) ; 6 . Non smoker ; 7 . Participants give his/her informed write consent . 1 . Asthma exacerbation 1 month prior study 2 . Clinically significant permanent allergy symptom ( ex . cat dog dander induce allergy ) 3 . Contraindications perform allergy skin test and/or bronchial provocation test 3.1 . Active airway infection 1 month prior study ; 3.2 . Used medicament : 3.2.1 . Inhaled glucocorticoid intake 1 month prior study ; 3.2.2 . Antihistamines intake 7 day prior study ; 3.2.3 . Short act β2 agonist 12 hour prior study ; 3.2.4 . Long act β2 agonist 2 day prior study ; 3.2.5 . Leukotriene receptor antagonists prior 14 day ; 4 . If histamine mean wheal diameter &lt; = 3 mm control mean wheal diameter &gt; = 3 mm ; 5 . Contraindications epinephrine ; 6 . Other significant mental / internal disease condition , could exclusion criterion due opinion researcher ; 7 . Alcohol narcotic abuse ; 8 . Pregnancy ; 9 . Breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>asthma</keyword>
	<keyword>eosinophil</keyword>
	<keyword>airway smooth muscle</keyword>
	<keyword>airway remodelling</keyword>
	<keyword>integrins</keyword>
	<keyword>cytokine</keyword>
</DOC>